JP2018520639A5 - - Google Patents

Download PDF

Info

Publication number
JP2018520639A5
JP2018520639A5 JP2017556123A JP2017556123A JP2018520639A5 JP 2018520639 A5 JP2018520639 A5 JP 2018520639A5 JP 2017556123 A JP2017556123 A JP 2017556123A JP 2017556123 A JP2017556123 A JP 2017556123A JP 2018520639 A5 JP2018520639 A5 JP 2018520639A5
Authority
JP
Japan
Prior art keywords
til
tcr
polynucleotide
cell
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017556123A
Other languages
English (en)
Japanese (ja)
Other versions
JP6894380B2 (ja
JP2018520639A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/029556 external-priority patent/WO2016176322A1/en
Publication of JP2018520639A publication Critical patent/JP2018520639A/ja
Publication of JP2018520639A5 publication Critical patent/JP2018520639A5/ja
Priority to JP2021093583A priority Critical patent/JP2021129601A/ja
Application granted granted Critical
Publication of JP6894380B2 publication Critical patent/JP6894380B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017556123A 2015-04-27 2016-04-27 治療用薬剤および疾患特異的抗原をシーケンシング、判定、ペアリングおよび検証する方法 Expired - Fee Related JP6894380B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021093583A JP2021129601A (ja) 2015-04-27 2021-06-03 治療用薬剤および疾患特異的抗原をシーケンシング、判定、ペアリングおよび検証する方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562153041P 2015-04-27 2015-04-27
US62/153,041 2015-04-27
PCT/US2016/029556 WO2016176322A1 (en) 2015-04-27 2016-04-27 Methods of sequencing, determining, pairing, and validating therapeutic agents and disease specific antigens

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021093583A Division JP2021129601A (ja) 2015-04-27 2021-06-03 治療用薬剤および疾患特異的抗原をシーケンシング、判定、ペアリングおよび検証する方法

Publications (3)

Publication Number Publication Date
JP2018520639A JP2018520639A (ja) 2018-08-02
JP2018520639A5 true JP2018520639A5 (cg-RX-API-DMAC7.html) 2019-06-06
JP6894380B2 JP6894380B2 (ja) 2021-06-30

Family

ID=57199815

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017556123A Expired - Fee Related JP6894380B2 (ja) 2015-04-27 2016-04-27 治療用薬剤および疾患特異的抗原をシーケンシング、判定、ペアリングおよび検証する方法
JP2021093583A Pending JP2021129601A (ja) 2015-04-27 2021-06-03 治療用薬剤および疾患特異的抗原をシーケンシング、判定、ペアリングおよび検証する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021093583A Pending JP2021129601A (ja) 2015-04-27 2021-06-03 治療用薬剤および疾患特異的抗原をシーケンシング、判定、ペアリングおよび検証する方法

Country Status (9)

Country Link
US (2) US10982258B2 (cg-RX-API-DMAC7.html)
EP (1) EP3289082A4 (cg-RX-API-DMAC7.html)
JP (2) JP6894380B2 (cg-RX-API-DMAC7.html)
CN (1) CN107849560B (cg-RX-API-DMAC7.html)
AU (1) AU2016253964B2 (cg-RX-API-DMAC7.html)
CA (1) CA2983937A1 (cg-RX-API-DMAC7.html)
HK (1) HK1252248A1 (cg-RX-API-DMAC7.html)
MX (1) MX2017013471A (cg-RX-API-DMAC7.html)
WO (1) WO2016176322A1 (cg-RX-API-DMAC7.html)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9951386B2 (en) 2014-06-26 2018-04-24 10X Genomics, Inc. Methods and systems for processing polynucleotides
EP4270006A3 (en) 2014-06-13 2024-01-10 Immudex ApS General detection and isolation of specific cells by binding of labeled molecules
US9975122B2 (en) 2014-11-05 2018-05-22 10X Genomics, Inc. Instrument systems for integrated sample processing
ES2768957T3 (es) 2015-09-24 2020-06-24 Abvitro Llc Composiciones de anticuerpos contra el VIH y métodos de uso
AU2016326734B2 (en) * 2015-09-25 2022-07-07 Abvitro Llc High throughput process for T cell receptor target identification of natively-paired T cell receptor sequences
WO2017197343A2 (en) 2016-05-12 2017-11-16 10X Genomics, Inc. Microfluidic on-chip filters
WO2017197338A1 (en) 2016-05-13 2017-11-16 10X Genomics, Inc. Microfluidic systems and methods of use
WO2017214557A1 (en) * 2016-06-10 2017-12-14 Counsyl, Inc. Nucleic acid sequencing adapters and uses thereof
US10011872B1 (en) 2016-12-22 2018-07-03 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10550429B2 (en) 2016-12-22 2020-02-04 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10815525B2 (en) 2016-12-22 2020-10-27 10X Genomics, Inc. Methods and systems for processing polynucleotides
IL315727A (en) 2016-12-23 2024-11-01 Visterra Inc Binding polypeptides and methods for their preparation
EP4310183B1 (en) 2017-01-30 2025-07-09 10X Genomics, Inc. Methods and systems for droplet-based single cell barcoding
US12264411B2 (en) 2017-01-30 2025-04-01 10X Genomics, Inc. Methods and systems for analysis
US12049667B2 (en) 2017-05-26 2024-07-30 Abvitro Llc High-throughput polynucleotide library sequencing and transcriptome analysis
EP4516896A3 (en) 2017-08-09 2025-05-14 Juno Therapeutics, Inc. Methods and compositions for preparing genetically engineered cells
MA50079A (fr) 2017-09-07 2020-07-15 Juno Therapeutics Inc Procédés d'identification de caractéristiques cellulaires relatives à des réponses associées à une thérapie cellulaire
WO2019084538A1 (en) * 2017-10-27 2019-05-02 Board Of Regents, The University Of Texas System TUMOR SPECIFIC ANTIBODIES, T CELL RECEPTORS AND METHODS OF IDENTIFICATION THEREOF
EP3724225A1 (en) 2017-12-15 2020-10-21 Juno Therapeutics, Inc. Anti-cct5 binding molecules and methods of use thereof
EP3752832A1 (en) 2018-02-12 2020-12-23 10X Genomics, Inc. Methods characterizing multiple analytes from individual cells or cell populations
WO2019217758A1 (en) 2018-05-10 2019-11-14 10X Genomics, Inc. Methods and systems for molecular library generation
WO2019241249A1 (en) * 2018-06-11 2019-12-19 The Brigham And Women's Hospital, Inc. Single cell cloning approaches for biological studies
WO2019238939A1 (en) 2018-06-15 2019-12-19 F. Hoffmann-La Roche Ag A system for identification of antigens recognized by t cell receptors expressed on tumor infiltrating lymphocytes
CN116298309B (zh) 2018-08-13 2024-04-02 根路径基因组学公司 成对的二分免疫受体多核苷酸的高通量克隆及其应用
WO2020082087A1 (en) * 2018-10-19 2020-04-23 Akoya Biosciences, Inc. Detection of co-occurring receptor-coding nucleic acid segments
EA202192103A1 (ru) 2019-01-29 2021-12-15 Джуно Терапьютикс, Инк. Антитела и химерные антигенные рецепторы, специфичные к орфанному рецептору типа рецеторной тирозинкиназы 1 (ror1)
MX2021012207A (es) 2019-04-05 2021-12-10 Rootpath Genomics Inc Composiciones y métodos para ensamblaje de genes del receptor de linfocitos t.
EP4058466A1 (en) * 2019-11-13 2022-09-21 Amunix Pharmaceuticals, Inc. Barcoded xten polypeptides and compositions thereof, and methods for making and using the same
US12449419B1 (en) 2020-02-12 2025-10-21 10X Genomics, Inc. Methods for detecting binding of peptide-MHC monomers to T cells
CN111218502B (zh) 2020-04-23 2020-07-21 圣湘生物科技股份有限公司 提升qPCR检测性能的组合物、反应液、用途及方法
KR20230024283A (ko) 2020-05-13 2023-02-20 주노 쎄러퓨티크스 인코퍼레이티드 임상 반응과 관련된 특징을 식별하는 방법 및 이의 용도
WO2022081643A2 (en) * 2020-10-13 2022-04-21 10X Genomics, Inc. Compositions and methods for generating recombinant antigen binding molecules from single cells
CN114464253B (zh) * 2022-03-03 2023-03-10 予果生物科技(北京)有限公司 基于长读长测序进行实时病原检测的方法、系统和应用
EP4519675A4 (en) * 2022-05-03 2026-04-08 3T Biosciences Inc T-LYMPHOCYTE TARGET DISCOVERY
EP4554973A1 (en) * 2022-07-13 2025-05-21 10X Genomics, Inc. Methods for characterization of antigen-binding molecules from biological samples
EP4680269A1 (en) 2023-03-13 2026-01-21 H. Lee Moffitt Cancer Center And Research Institute, Inc. Composition of selected tumor infiltrating lymphocytes and related methods of producing and using the same
GB2629157A (en) * 2023-04-18 2024-10-23 The Institute Of Cancer Res Royal Cancer Hospital T cell receptor sequencing
WO2025080865A1 (en) 2023-10-11 2025-04-17 Turnstone Biologics Corp. Combination of tumor infiltrating lymphocytes (til) and low dose radiation
WO2025096638A2 (en) 2023-10-30 2025-05-08 Turnstone Biologics Corp. Genetically modified tumor infilitrating lymphocytes and methods of producing and using the same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990004648A1 (en) 1988-10-20 1990-05-03 Alexander Alan Morley Method for diagnosis of monoclonality in leukaemia and lymphoma
US20070160994A1 (en) 2003-12-15 2007-07-12 Institut Pasteur Repertoire determination of a lymphocyte b population
US8268564B2 (en) * 2007-09-26 2012-09-18 President And Fellows Of Harvard College Methods and applications for stitched DNA barcodes
EP2364368B1 (en) 2008-11-07 2014-01-15 Sequenta, Inc. Methods of monitoring conditions by sequence analysis
US10385391B2 (en) * 2009-09-22 2019-08-20 President And Fellows Of Harvard College Entangled mate sequencing
CN103703143B (zh) * 2011-01-31 2016-12-14 爱普瑞斯生物公司 鉴定细胞中的多个表位的方法
SG10201900183VA (en) * 2011-04-28 2019-05-30 Univ Leland Stanford Junior Identification of polynucleotides associated with a sample
SI2755997T1 (sl) * 2011-09-15 2018-11-30 The United States of America, as represented by Secretary, Department of Health and Human Services, Office of Technology Transfer, National Institutes of Health T-celični receptorji, ki prepoznajo HLA-A1- ali HLA-CW7-omejeni mage
HK1201565A1 (en) * 2011-10-21 2015-09-04 Adaptive Biotechnologies Corporation Quantification of adaptive immune cell genomes in a complex mixture of cells
JP6558830B2 (ja) 2012-06-15 2019-08-14 ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム 複数転写産物のハイスループットシークエンシング
ES2748204T3 (es) * 2013-02-22 2020-03-13 Adaptive Biotechnologies Corp Procedimiento para seleccionar clonotipos raros
WO2014144495A1 (en) * 2013-03-15 2014-09-18 Abvitro, Inc. Single cell bar-coding for antibody discovery
CA2906218A1 (en) * 2013-03-15 2014-09-18 Adaptive Biotechnologies Corporation Uniquely tagged rearranged adaptive immune receptor genes in a complex gene set
CN105705659B (zh) * 2013-08-28 2019-11-29 贝克顿迪金森公司 大规模平行单细胞分析
CN107074957B (zh) * 2014-01-13 2021-05-07 希望之城公司 在Fc间隔物区中具有突变的嵌合抗原受体(CAR)及其使用方法
US10590483B2 (en) 2014-09-15 2020-03-17 Abvitro Llc High-throughput nucleotide library sequencing
CN107530654A (zh) * 2015-02-04 2018-01-02 加利福尼亚大学董事会 通过在离散实体中条形码化对核酸进行测序

Similar Documents

Publication Publication Date Title
JP6681131B2 (ja) 産生宿主における抗体/タンパク質パフォーマンス及び発現の同時で統合された選択及び進化
JP5054058B2 (ja) ハイブリッド抗体
US20040086979A1 (en) Humanized rabbit antibodies
CN105602960A (zh) 抗体的快速人源化
CN108220297A (zh) 用于生成单克隆抗体的方法和试剂
Kirik et al. Antibody heavy chain variable domains of different germline gene origins diversify through different paths
CN105924499A (zh) 蛋白演化的新方法
WO2023154533A2 (en) Combinatorial dna assembly for multispecific antibodies
JP2012508022A (ja) 減少した免疫原性を有する操作された抗体および作製方法
Anderson et al. Evolution of immunoglobulin heavy chain variable region genes: a VH family can last for 150–200 million years or longer
US20250012808A1 (en) Parallel antibody engineering compositions and methods
Wang et al. Evidence of IgY subclass diversification in snakes: evolutionary implications
Weiss-Ottolenghi et al. Profiling the IgOme: meeting the challenge
JP6665274B2 (ja) 標的分子に結合するポリペプチドの決定方法及び決定システム
CN115485392A (zh) 用于鉴别配体阻断性抗体及用于确定抗体效价的方法
US20210054434A1 (en) Kit for amplifying immunoglobulin sequences
US20230142800A1 (en) Adalimumab Variants with Reduced Immunogenic Potential
Rothenfluh et al. Origin and maintenance of germ‐line V genes
US20250115898A1 (en) Systems and methods for simultaneous detection of antigens and ligands thereof
Trimmer Keith G. Mitchell, Belvin Gong, Samuel S. Hunter 2, Diana Burkart‑Waco 3, Clara E. Gavira‑O’Neill, Kayla M. Templeton, Madeline E. Goethel, Malgorzata Bzymek, Leah M. MacNiven, Karl D. Murray, Matthew L. Settles 2, Lutz Froenicke 3 &
Robinson Leveraging BCR data to improve computational design of therapeutic antibodies
US20090318308A1 (en) Highly diversified antibody libraries
CN121895443A (zh) 一种针对人SARS-CoV-2的单克隆抗体、其制备方法及应用
US20250340861A1 (en) Display technology libra-seq and methods of use thereof
Mitchell et al. NeuroMabSeq: high volume acquisition, processing, and curation of hybridoma sequences and their use in generating recombinant monoclonal antibodies and scFvs for neuroscience research